![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, January 29, 2010 2:55:09 PM
Shares of Adventrx Pharmaceuticals, Inc. (AMEX:ANX) dipped down to below thirty cents again on Thursday after having risen to a high of over fifty cents earlier this month when the company announced an NDA filing for ANX-530. The news of the NDA was followed by a stock offering.
ADVENTRX PHARMACEUTICALS, Inc.
0.28 +0.00 (+0.11%)
Intraday | 3 Month | 6 Month | 1 Year
Quotes delayed at least 20 mins.
Those looking to speculate on the ANX-530 position could be looking at a nice entry point, in my opinion, below thirty cents. I feel we'll see at least fifty cents again before the FDA decision is announced - maybe more, depending on the market.
Buy the dips and play the volatility here, in my position.
Vinny Cassano also authors the popular biotech stock blog VFC's Stock House. He is long ANX, BMSN and SIGA
Recent MSTX News
- NYSE and Nasdaq Pull ETF Options Requests, 75% of Bitcoins Remain Inactive, MakerDAO Halts WBTC Loans • IH Market News • 08/16/2024 07:25:47 PM
- Deutsche Bank Faces Shareholder Backlash, Bank of America Sponsors 2026 World Cup, Quanterix CEO Buys More Shares • IH Market News • 08/16/2024 10:03:21 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM